Brokers Set Expectations for Palomar FY2026 Earnings

Palomar Holdings, Inc. (NASDAQ:PLMR) – Research analysts at DOWLING & PARTN issued their FY2026 earnings estimates for Palomar in a research report issued on Wednesday, May 20th. DOWLING & PARTN analyst N. Iacoviello forecasts that the company will post earnings of $8.53 per share for the year. The consensus estimate for Palomar’s current full-year earnings is $9.02 per share. DOWLING & PARTN also issued estimates for Palomar’s FY2027 earnings at $9.82 EPS.

Several other equities research analysts also recently weighed in on the company. Keefe, Bruyette & Woods cut their price target on Palomar from $186.00 to $159.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Wall Street Zen lowered Palomar from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Zacks Research lowered Palomar from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 15th. Evercore assumed coverage on Palomar in a research note on Monday, February 9th. They set an “outperform” rating and a $150.00 price objective for the company. Finally, Weiss Ratings lowered Palomar from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Palomar has an average rating of “Moderate Buy” and a consensus price target of $147.75.

Palomar Price Performance

Shares of PLMR opened at $109.45 on Thursday. The firm has a market capitalization of $2.90 billion, a PE ratio of 15.24 and a beta of 0.49. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.49 and a quick ratio of 0.49. Palomar has a 1-year low of $107.51 and a 1-year high of $175.85. The company’s fifty day moving average price is $120.21 and its 200-day moving average price is $124.47.

Palomar (NASDAQ:PLMR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.17 by $0.14. The firm had revenue of $278.94 million for the quarter, compared to analyst estimates of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The business’s quarterly revenue was up 59.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.87 earnings per share.

Insider Transactions at Palomar

In other news, President Jon Christianson sold 3,000 shares of the stock in a transaction dated Tuesday, April 7th. The shares were sold at an average price of $125.00, for a total transaction of $375,000.00. Following the sale, the president directly owned 62,919 shares of the company’s stock, valued at $7,864,875. This represents a 4.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mac Armstrong sold 3,500 shares of the firm’s stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $120.58, for a total value of $422,030.00. Following the sale, the chief executive officer owned 339,888 shares in the company, valued at $40,983,695.04. This trade represents a 1.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 18,634 shares of company stock valued at $2,318,111 in the last quarter. Company insiders own 3.70% of the company’s stock.

Institutional Investors Weigh In On Palomar

Institutional investors have recently modified their holdings of the business. Geneos Wealth Management Inc. acquired a new stake in shares of Palomar during the 4th quarter valued at about $32,000. Kestra Advisory Services LLC purchased a new stake in shares of Palomar in the fourth quarter valued at approximately $33,000. Rockefeller Capital Management L.P. increased its position in shares of Palomar by 81.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after buying an additional 132 shares in the last quarter. Clearstead Advisors LLC increased its position in shares of Palomar by 31.0% in the third quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock valued at $46,000 after buying an additional 94 shares in the last quarter. Finally, Frazier Financial Advisors LLC purchased a new position in shares of Palomar during the 4th quarter valued at approximately $54,000. 90.25% of the stock is currently owned by institutional investors and hedge funds.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.